journal article·2024-02-12

Study on Synergistic Effects of Nanohydroxyapatite/High-Viscosity Carboxymethyl Cellulose Scaffolds Stimulated by LIPUS for Bone Defect Repair of Rats

Liang Tang, Tianpei Wu, Jiaxiang Li, Yanan Yu, Zhanke Ma, Lijun Sun, Dean Ta, Xiushan Fan

Publisher page

Abstract

Despite the self-healing capacity of bone, the regeneration of critical-size bone defects remains a major clinical challenge. In this study, nanohydroxyapatite (nHAP)/high-viscosity carboxymethyl cellulose (hvCMC, 6500 mPa·s) scaffolds and low-intensity pulsed ultrasound (HA-LIPUS) were employed to repair bone defects. First, hvCMC was prepared from ramie fiber, and the degree of substitution (DS), purity, and content of NaCl of hvCMC samples were 0.91, 99.93, and 0.017%, respectively. Besides, toxic metal contents were below the permissible limits for pharmaceutically used materials. Our results demonstrated that the hvCMC is suitable for pharmaceutical use. Second, nHAP and hvCMC were employed to prepare scaffolds by freeze-drying. The results indicated that the scaffolds were porous, and the porosity was 35.63 ± 3.52%. Subsequently, the rats were divided into four groups ( n = 8) randomly: normal control (NC), bone defect (BD), bone defect treated with nHAP/hvCMC scaffolds (HA), and bone defect treated with nHAP/hvCMC scaffolds and stimulated by LIPUS (HA-LIPUS). After drilling surgery, nHAP/hvCMC scaffolds were implanted in the defect region of HA and HA-LIPUS rats. Meanwhile, HA-LIPUS rats were treated by LIPUS (1.5 MHz, 80 mW cm –2 ) irradiation for 2 weeks. Compared with BD rats, the maximum load and bone mineral density of HA-LIPUS rats were increased by 20.85 and 51.97%, respectively. The gene and protein results indicated that nHAP/hvCMC scaffolds and LIPUS promoted the bone defect repair and regeneration of rats significantly by activating Wnt/β-catenin and inhibiting OPG/RANKL signaling pathways. Overall, compared with BD rats, nHAP/hvCMC scaffolds and LIPUS promoted bone defect repair significantly. Furthermore, the research results also indicated that there are synergistic effects for bone defect repair between the nHAP/hvCMC scaffolds and LIPUS.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Graphene and Nanomaterials Applications · Facial Trauma and Fracture Management

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Sports Biology, Shaanxi Normal University, Xi’an 710119, China

Center for Biomedical Engineering, School of Information Science and Technology, Fudan University, Shanghai 200433, China

Department of Rehabilitation Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China

Funding

National Natural Science Foundation of China · Shaanxi Normal University

References (75)

Show source-provided references
1. 10.3389/fbioe.2018.0010510.3389/fbioe.2018.00105 ↗
2. 10.1111/iwj.1223110.1111/iwj.12231 ↗
3. 10.1155/2018/412637910.1155/2018/4126379 ↗
4. 10.1016/j.jmbbm.2007.07.00110.1016/j.jmbbm.2007.07.001 ↗
5. 10.1016/j.jbiomech.2013.12.00310.1016/j.jbiomech.2013.12.003 ↗
6. 10.1016/j.actbio.2010.02.02810.1016/j.actbio.2010.02.028 ↗
7. 10.1097/00006534-199710000-0004310.1097/00006534-199710000-00043 ↗
8. 10.1002/jbm.a.3283410.1002/jbm.a.32834 ↗
9. 10.1002/adfm.20110308310.1002/adfm.201103083 ↗
10. 10.1016/j.carbpol.2011.04.01510.1016/j.carbpol.2011.04.015 ↗
11. 10.1016/j.msec.2017.05.13310.1016/j.msec.2017.05.133 ↗
12. 10.1016/j.ijbiomac.2018.01.18110.1016/j.ijbiomac.2018.01.181 ↗
13. 10.2147/IJN.S15460510.2147/IJN.S154605 ↗
14. 10.1021/acsami.8b0605510.1021/acsami.8b06055 ↗
15. 10.1021/acs.biomac.8b0070710.1021/acs.biomac.8b00707 ↗
16. 10.1016/j.msec.2019.03.07710.1016/j.msec.2019.03.077 ↗
17. 10.1016/j.msec.2019.03.01410.1016/j.msec.2019.03.014 ↗
18. 10.1007/s00223-017-0294-z10.1007/s00223-017-0294-z ↗
19. 10.2147/IJN.S9034310.2147/IJN.S90343 ↗
20. 10.1016/j.eurpolymj.2021.11036010.1016/j.eurpolymj.2021.110360 ↗
21. 10.1016/j.actbio.2011.03.01910.1016/j.actbio.2011.03.019 ↗
22. 10.1016/j.carbpol.2016.02.01510.1016/j.carbpol.2016.02.015 ↗
23. 10.1021/acsami.6b0081510.1021/acsami.6b00815 ↗
24. 10.1021/acsami.6b1478210.1021/acsami.6b14782 ↗
25. 10.1016/S0142-9612(99)00020-410.1016/S0142-9612(99)00020-4 ↗
26. 10.1002/jbm.a.3174410.1002/jbm.a.31744 ↗
27. 10.4236/msa.2010.1201510.4236/msa.2010.12015 ↗
28. 10.1021/acsbiomaterials.9b0138110.1021/acsbiomaterials.9b01381 ↗
29. 10.1002/adma.20170017110.1002/adma.201700171 ↗
30. 10.1016/j.apmt.2017.12.00410.1016/j.apmt.2017.12.004 ↗
31. 10.1016/j.jmrt.2023.02.17110.1016/j.jmrt.2023.02.171 ↗
32. 10.1016/j.mattod.2020.03.00310.1016/j.mattod.2020.03.003 ↗
33. 10.1002/adfm.20180843910.1002/adfm.201808439 ↗
34. 10.1016/j.ijbiomac.2011.01.01210.1016/j.ijbiomac.2011.01.012 ↗
35. 10.1016/j.biomaterials.2009.09.05910.1016/j.biomaterials.2009.09.059 ↗
36. 10.1016/j.carbpol.2016.05.08810.1016/j.carbpol.2016.05.088 ↗
37. 10.1016/j.msec.2019.03.01510.1016/j.msec.2019.03.015 ↗
38. 10.1016/j.cclet.2023.10919710.1016/j.cclet.2023.109197 ↗
39. 10.1016/j.carbpol.2020.11668310.1016/j.carbpol.2020.116683 ↗
40. 10.1016/j.actbio.2019.01.01410.1016/j.actbio.2019.01.014 ↗
41. 10.1016/j.msec.2019.02.10410.1016/j.msec.2019.02.104 ↗
42. 10.1016/j.carbpol.2022.11914210.1016/j.carbpol.2022.119142 ↗
43. 10.1016/j.carbpol.2004.06.03410.1016/j.carbpol.2004.06.034 ↗
44. 10.1016/S0144-8617(03)00147-410.1016/S0144-8617(03)00147-4 ↗
45. 10.1016/j.lwt.2012.02.02910.1016/j.lwt.2012.02.029 ↗
46. 10.1016/j.carbpol.2005.12.00310.1016/j.carbpol.2005.12.003 ↗
47. 10.1016/j.ijbiomac.2015.04.06110.1016/j.ijbiomac.2015.04.061 ↗
48. 10.1007/s12221-012-0748-x10.1007/s12221-012-0748-x ↗
49. 10.1016/j.indcrop.2019.05.02910.1016/j.indcrop.2019.05.029 ↗
50. 10.1016/j.bone.2018.01.02510.1016/j.bone.2018.01.025 ↗
51. 10.1007/s00402-016-2501-110.1007/s00402-016-2501-1 ↗
52. 10.1007/s00264-013-2254-110.1007/s00264-013-2254-1 ↗
53. 10.1093/ptj/86.8.111810.1093/ptj/86.8.1118 ↗
54. 10.1016/j.injury.2008.04.00410.1016/j.injury.2008.04.004 ↗
55. 10.1016/j.ultrasmedbio.2005.06.00210.1016/j.ultrasmedbio.2005.06.002 ↗
56. 10.1016/j.ultrasmedbio.2003.11.00810.1016/j.ultrasmedbio.2003.11.008 ↗
57. 10.1016/j.bone.2020.11561010.1016/j.bone.2020.115610 ↗
58. 10.1016/j.carbpol.2018.02.01610.1016/j.carbpol.2018.02.016 ↗
59. 10.1016/j.msec.2015.04.03310.1016/j.msec.2015.04.033 ↗
60. 10.1021/acsnano.6b0713810.1021/acsnano.6b07138 ↗
61. 10.1021/acsabm.8b0059910.1021/acsabm.8b00599 ↗
62. 10.1016/j.actbio.2014.03.02110.1016/j.actbio.2014.03.021 ↗
63. 10.1016/j.carbpol.2014.08.00510.1016/j.carbpol.2014.08.005 ↗
64. 10.1055/s-0033-135846810.1055/s-0033-1358468 ↗
65. 10.4049/jimmunol.110338710.4049/jimmunol.1103387 ↗
66. 10.1371/journal.pone.000543810.1371/journal.pone.0005438 ↗
67. 10.3390/ijms2022552510.3390/ijms20225525 ↗
68. 10.1016/j.coph.2018.04.01110.1016/j.coph.2018.04.011 ↗
69. 10.1002/jcp.2421810.1002/jcp.24218 ↗
70. 10.1021/acsami.6b0110310.1021/acsami.6b01103 ↗
71. 10.1016/j.biomaterials.2016.10.00910.1016/j.biomaterials.2016.10.009 ↗
72. 10.1016/j.ultras.2017.11.01110.1016/j.ultras.2017.11.011 ↗
73. 10.1016/j.febslet.2014.12.01310.1016/j.febslet.2014.12.013 ↗
74. 10.1515/bmt-2015-016610.1515/bmt-2015-0166 ↗
75. 10.1007/s10439-017-1949-710.1007/s10439-017-1949-7 ↗